<!doctype html><html><head><meta charset=utf-8><title>Breast Cancer survival improved 3.6X by 2,000 IU of Vitamin D with chemotherapy – RCT</title>
<link rel=stylesheet href="/css/main.css?v=1748384339"><link rel=stylesheet href="/css/pagination.css?v=1748384339"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748384339"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Breast Cancer survival improved 3.6X by 2,000 IU of Vitamin D with chemotherapy – RCT</h1><time>March 18, 2025</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#vitamin-d-supplementation-improves-pathological-complete-response-in-breast-cancer-patients-undergoing-neoadjuvant-chemotherapy-a-randomized-clinical-trial>Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial</a></li><li><a href=#see-related-in-vitamindwiki>See related in VitaminDWiki</a></li></ul></li></ul></li></ul></nav><hr><h4 id=vitamin-d-supplementation-improves-pathological-complete-response-in-breast-cancer-patients-undergoing-neoadjuvant-chemotherapy-a-randomized-clinical-trial>Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial</h4><p>Nutr Cancer. 2025 Mar 17:1-10. <a href=https://doi.org/10.1080/01635581.2025.2480854>doi: 10.1080/01635581.2025.2480854</a> PDF is behind paywall</p><p>Michelle Sako Omodei 1, Jackeline Chimicoviaki 1, Daniel Araujo Brito Buttros 1, Benedito Souza Almeida-Filho 2, Carla Priscila Carvalho-Pessoa 2, Eduardo Carvalho-Pessoa 1 2, Heloisa De Luca Vespoli 1 2, Eliana Aguiar Petri Nahas 1 2</p><p>This study aimed to evaluate the effect of vitamin D (VD) supplementation on the pathological complete response (pCR) rate in women with breast cancer (BC) undergoing neoadjuvant chemotherapy (NCT). A randomized clinical trial was conducted with 80 women aged ≥45years with BC who were eligible for NCT. Women were randomized into two groups: VD group, daily supplementation with 2,000IU of cholecalciferol (n = 40) or placebo (n = 40), for 6 months. The primary outcome measure was the pCR rate. Serum 25-hydroxyvitamin-D <span>[25(OH)D]</span> levels were measured after BC diagnosis and the end of NCT. Of the 80 randomized women, 75 completed the NCT and underwent surgery. Baseline 25(OH)D values indicated hypovitaminosis D in both groups (VD: 19.6 ± 5.8 ng/mL and placebo: 21 ± 7.9 ng/mL, p = 0.33). After 6 months, 25(OH)D levels increased in the VD group compared to the placebo group (28 ± 8.7 vs. 20.2 ± 6.1 ng/mL, p = 0.03). The pCR rate was higher in women supplemented with VD when compared than the placebo (43% vs. 24%, p = 0.04).</p><p>Adjusted logistic regression showed that women with 25(OH)D <strong>levels ≥20ng/mL</strong> were more likely to achieve pCR (OR <strong>3.65</strong> , 95%CI 1.09-12.8, p = 0.04). Women with BC undergoing NCT who received supplementation with 2,000IU of VD were more likely to achieve a pathological complete response than women in the placebo group.</p><p><strong><a href=https://www.perplexity.ai/search/what-is-neoadjuvant-chemothera-sUthjjT4RQSAylI4W9iemQ>Asked Perplexity AI several questions to understand this abstract</a></strong></p><hr><h5 id=anticipate-even-better-long-term-survival-if-any-of-4-changes>Anticipate even better long-term survival if any of 4 changes:</h5><ol><li><p>Started the vitamin D months before the surgery</p></li><li><p>Used a larger daily dose of vitamin D</p></li><li><p>Had used a loading dose to raise the vitamin D levels in weeks, not months</p></li><li><p>Had used a loading dose of vitamin D before the subsequent surgery</p></li></ol><blockquote><p>    <a href=/posts/large-dose-vitamin-d-before-surgery-was-found-to-help-by-35-studies style=color:red;text-decoration:underline title="This post/category does not exist yet: Large dose Vitamin D before surgery was found to help by 35 studies">Large dose Vitamin D before surgery was found to help by 35 studies</a></p></blockquote><hr><h4 id=see-related-in-vitamindwiki>See related in VitaminDWiki</h4><ul><li><p><a href=/posts/breast-cancer-chemo-35-percent-more-likely-to-be-successful-if-more-than-20-ng-o-d-meta-analysis>Breast Cancer Chemo 35% more likely to be successful if more than 20 ng of Vitamin D – meta-analysis Dec 2024</a></p></li><li><p><a href=/posts/breast-cancer-survivors-with-high-vitamin-d-were-33-x-less-likely-to-have-metastases style=color:red;text-decoration:underline title="This post/category does not exist yet: Breast Cancer survivors with high vitamin D were 3.3 X less likely to have metastases – May 2023">Breast Cancer survivors with high vitamin D were 3.3 X less likely to have metastases – May 2023</a></p></li><li><p><a href=/posts/breast-cancers-with-the-lowest-vitamin-d-levels-were-more-likely-to-metastasize style=color:red;text-decoration:underline title="This post/category does not exist yet: Breast Cancers with the lowest Vitamin D levels were more likely to metastasize – Sept 2022">Breast Cancers with the lowest Vitamin D levels were more likely to metastasize – Sept 2022</a></p></li><li><p><a href=/posts/half-of-breast-cancer-patients-opt-for-vitamin-d-german-survey style=color:red;text-decoration:underline title="This post/category does not exist yet: Half of Breast Cancer patients opt for vitamin D (German survey) – Jan 2021">Half of Breast Cancer patients opt for vitamin D (German survey) – Jan 2021</a></p></li><li><p><a href=/posts/85-percent-less-risk-of-death-from-breast-cancer-when-vitamin-d-levels-higher-than-30-ng style=color:red;text-decoration:underline title="This post/category does not exist yet: 85 percent less risk of death from Breast Cancer when vitamin D levels higher than 30 ng – May 2012">85 percent less risk of death from Breast Cancer when vitamin D levels higher than 30 ng – May 2012</a></p></li><li><p><a href=/posts/breast-cancer-chemotherapy-27-x-more-likely-to-be-successful-if-not-vitamin-d-deficient style=color:red;text-decoration:underline title="This post/category does not exist yet: Breast Cancer chemotherapy 2.7 X more likely to be successful if not vitamin D deficient – Dec 2017">Breast Cancer chemotherapy 2.7 X more likely to be successful if not vitamin D deficient – Dec 2017</a></p></li><li><p><a href=/posts/chemotherapy-and-vitamin-d-many-studies style=color:red;text-decoration:underline title="This post/category does not exist yet: Chemotherapy and vitamin D - many studies">Chemotherapy and vitamin D - many studies</a></p><ul><li>More vitamin D is better, but Vitamin D increases the potency of some chemo drugs, to the point of becoming deadly if the dose is not reduced</li></ul></li></ul></article></div></div><script src="/js/lightspa.js?v=1748384339"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748384339",indexUrl:"/search/search_index.json.gz?v=1748384339"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748384339"></script><script src="/js/search-results-panel.js?v=1748384339"></script><script src="/js/tiki-redirects.js?v=1748384339"></script></body></html>